Search Results 641-650 of 13935 for Assay
This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...
... assays. The cohort will also be useful for clinical validation and assessment of clinical utility of predictive and prognostic biomarkers for breast cancer ...
CfDNA Assay Prospective Observational Validation For Early Cancer Detection And Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...
She evaluates rapid phenotypic assays, molecular detection platforms and next‑generation sequencing workflows — including metagenomic and long‑read whole ...
By combining data from neuroimaging, sensory testing and biomarker assays, she has developed a stratified medicine framework that predicts treatment response ...
Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...
Notably, patients without prior treatment exhibited the highest incidence of this mutation, suggesting that for optimal yield, ctDNA assays should be performed ...
Cytogenetics Core. Sections. Overview · Faculty and staff; Services Services. Services · Cell culture · Fluorescence in situ hybridization · OncoScan assay ...
... use the same process again, and just put a different assay at the end to detect a different pathogen." For the Mayo Clinic News Network, I'm DeeDee. Stiepan.
Recent advances have enabled application of technologies such as assay for transposase-accessible chromatin sequencing (ATAC-seq) and RNA sequencing (RNA-seq) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.